Immunotherapy with monoclonal antibody (mAb)-vehicled toxins may be a novel treatment option for the management of androgen-independent Prostate Cancer. To investigate the therapeutic potential of anti-prostate specific membrane antigen (PSMA) mAb-ricin A-chain Immunotoxins (ITS) in monolayer and 3D cell cultures of prostate carcinoma cell lines (LNCaP), (J591, PEQ226.5, PM2PO79.1).

Anti PSMA immunotoxins activity against prostate cancer cell lines.

FRACASSO, Giulio;CINGARLINI, Sara;BELLISOLA, GIUSEPPE;RIGHETTI, Sabrina;CHIESA, ELENA;COLOMBATTI, Marco
2002

Abstract

Immunotherapy with monoclonal antibody (mAb)-vehicled toxins may be a novel treatment option for the management of androgen-independent Prostate Cancer. To investigate the therapeutic potential of anti-prostate specific membrane antigen (PSMA) mAb-ricin A-chain Immunotoxins (ITS) in monolayer and 3D cell cultures of prostate carcinoma cell lines (LNCaP), (J591, PEQ226.5, PM2PO79.1).
ricin; immunotoxins; Prostate Specific Membrane Antigen (PSMA); prostate cancer
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/20213
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact